Susan Dexter - 14 Jun 2023 Form 4 Insider Report for Sonnet BioTherapeutics Holdings, Inc. (SONN)

Role: Chief Technical Officer
Signature: /s/ John Harry Cross III, power of attorney
Issuer symbol: SONN
Transactions as of: 14 Jun 2023
Net transactions value: +$7,000
Form type: 4
Filing time: 15 Jun 2023, 16:15:18 UTC
Previous filing: 17 Feb 2023
Next filing: 05 Dec 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SONN	Common Stock	Purchase	$7,000	+10,000	+42%	$0.7000	33,667	14 Jun 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6972 to $0.6999 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
F2	Includes unvested restricted stock awards.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6972 to $0.6999 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.

Includes unvested restricted stock awards.